Min Yang

When idiopathic multicentric Castleman disease meets COVID-19: a multicenter retrospective study from China

L. You, Yunfei Lv, Yi Liu, 2024, Therapeutic advances in hematology.

Phosphoproteomic Characterization and Kinase Signature Predict Response to Venetoclax Plus 3+7 Chemotherapy in Acute Myeloid Leukemia

Li-ping Mao, Huafeng Wang, Hongyan Tong, 2023, Advanced science.

Harnessing Nanotechnology: Emerging Strategies for Multiple Myeloma Therapy

H. Tong, L. You, Li Zhu, 2024, Biomolecules.

Homoharringtonine synergizes with venetoclax in early T cell progenitor acute lymphoblastic leukemia: Bench and bed.

Fengling Li, L. Nguyen, Dinh Hoa Hoang, 2024, Med.

Venetoclax plus daunorubicin and cytarabine in newly diagnosed acute myeloid leukemia patients: A propensity score‐matched analysis

H. Tong, W. Mai, W. Xie, 2024, Hematological oncology.